Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mycosis Fungoides (MF)”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06035497
What this trial is testing

Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

Who this might be right for
Relapsed or Refractory T-cell Lymphomas
Bristol-Myers Squibb 85
Testing effectiveness (Phase 2)Study completedNCT05380635
What this trial is testing

PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma

Who this might be right for
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Soligenix 9
Very early researchTemporarily pausedNCT06235281
What this trial is testing

Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT)

Who this might be right for
Mycosis Fungoides
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT00168064
What this trial is testing

Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides

Who this might be right for
Mycosis Fungoides
Yaupon Therapeutics 260
Testing effectiveness (Phase 2)Ended earlyNCT01579318
What this trial is testing

Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma

Who this might be right for
Cutaneous T Cell Lymphomas (CTCL)Mycosis Fungoides (MF)
OncoSec Medical Incorporated 2
Early research (Phase 1)Active Not RecruitingNCT04652960
What this trial is testing

Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome

Who this might be right for
Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8
National Cancer Institute (NCI) 38
Large-scale testing (Phase 3)Study completedNCT02448381
What this trial is testing

FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)

Who this might be right for
Cutaneous T-Cell Lymphoma
Soligenix 169
Testing effectiveness (Phase 2)Active Not RecruitingNCT01352520
What this trial is testing

SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)

Who this might be right for
CD-30 Positive Anaplastic Large T-cell Cutaneous LymphomaLymphoma, Primary Cutaneous Anaplastic Large CellLymphomatoid Papulosis+5 more
M.D. Anderson Cancer Center 79
Testing effectiveness (Phase 2)WithdrawnNCT02943642
What this trial is testing

Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides

Who this might be right for
Mycosis Fungoides
Virogen Biotechnology Inc.
Not applicableStudy completedNCT02296164
What this trial is testing

Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma

Who this might be right for
Mycosis Fungoides
Helsinn Therapeutics (U.S.), Inc 300
Testing effectiveness (Phase 2)Study completedNCT03380026
What this trial is testing

Mechlorethamine Induced Contact Dermatitis Avoidance Study

Who this might be right for
Cutaneous T-cell LymphomaCutaneous T-cell Lymphoma Stage IMycosis Fungoides+5 more
Rochester Skin Lymphoma Medical Group, PLLC 28
Testing effectiveness (Phase 2)WithdrawnNCT00969085
What this trial is testing

Trial of Curcumin in Cutaneous T-cell Lymphoma Patients

Who this might be right for
Cutaneous T-cell Lymphoma
M.D. Anderson Cancer Center
Not applicableStudy completedNCT05303480
What this trial is testing

Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides

Who this might be right for
Mycosis Fungoides
Centre for Human Drug Research, Netherlands 32
Testing effectiveness (Phase 2)Study completedNCT02953301
What this trial is testing

Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)

Who this might be right for
Mycosis FungoidesSezary SyndromeLymphoma, T-Cell, Cutaneous
4SC AG 201
Testing effectiveness (Phase 2)Ended earlyNCT03713320
What this trial is testing

SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects With Mycosis Fungoides

Who this might be right for
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
miRagen Therapeutics, Inc. 37
Not applicableUnknownNCT06421571
What this trial is testing

The Mechanism of Action of Chlormethine (CL) Gel in the Treatment of MF-CTCL Adult Patients

Who this might be right for
Mycosis Fungoides
National and Kapodistrian University of Athens 40
Testing effectiveness (Phase 2)WithdrawnNCT03563040
What this trial is testing

Study of Photopheresis in the Treatment of Erythrodermic MF and SS

Who this might be right for
Lymphoma, T-Cell, CutaneousMycosis Fungoides/Sezary Syndrome
European Organisation for Research and Treatment of Cancer - EORTC
Post-approval studies (Phase 4)Study completedNCT01007448
What this trial is testing

Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

Who this might be right for
Refractory Cutaneous T-cell Lymphoma
Bausch Health Americas, Inc. 59
Testing effectiveness (Phase 2)Ended earlyNCT00052377
What this trial is testing

Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides

Who this might be right for
Recurrent Cutaneous T-cell Non-Hodgkin LymphomaRecurrent Mycosis Fungoides/Sezary SyndromeStage I Cutaneous T-cell Non-Hodgkin Lymphoma+7 more
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Ended earlyNCT01187446
What this trial is testing

Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides

Who this might be right for
Cutaneous LymphomaCutaneous T-cell Lymphoma
Stanford University 28
Next Page